About Timothy Andrews
Form D filings for Mirador Therapeutics in 2024 list Timothy Andrews as secretary.
Timothy Andrews reports to the SEC as an officer of 2 public companies: Prometheus Biosciences (RXDX) and Sienna Biopharmaceuticals (SNNA).
Timothy Andrews first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Andrews in the role, so the role may have started earlier or lasted longer.
PI
Prometheus Biosciences, Inc.
General Counsel
2021 · Public company (RXDX)
SI
Sienna Biopharmaceuticals, Inc.
General Counsel & Secretary
2017 – 2019 · Public company (SNNA)
Key Colleagues at Startups
The people Timothy Andrews works with at each company, as listed on that company's latest Form D.
Mirador Therapeutics, Inc. · Form D, Apr 3, 2024
PB
Paul Berns
Director
JP
Joseph Papa
Director
MM
Mark McKenna
Executive officer and director
SG
Scott Glenn
Director
KB
Kristina Burow
Director
VB
Vika Brough
Executive officer
DD
David Bonita, M.D.
Director